DK2074123T3 - Nye anxiolytiske forbindelser - Google Patents
Nye anxiolytiske forbindelserInfo
- Publication number
- DK2074123T3 DK2074123T3 DK07815371.5T DK07815371T DK2074123T3 DK 2074123 T3 DK2074123 T3 DK 2074123T3 DK 07815371 T DK07815371 T DK 07815371T DK 2074123 T3 DK2074123 T3 DK 2074123T3
- Authority
- DK
- Denmark
- Prior art keywords
- anxiolytic compounds
- new anxiolytic
- new
- compounds
- anxiolytic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Anesthesiology (AREA)
- Epidemiology (AREA)
- Addiction (AREA)
- Hospice & Palliative Care (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US85198306P | 2006-10-16 | 2006-10-16 | |
PCT/AU2007/001566 WO2008046135A1 (en) | 2006-10-16 | 2007-10-16 | Novel anxiolytic compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
DK2074123T3 true DK2074123T3 (da) | 2013-01-14 |
Family
ID=39313499
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK07815371.5T DK2074123T3 (da) | 2006-10-16 | 2007-10-16 | Nye anxiolytiske forbindelser |
Country Status (13)
Country | Link |
---|---|
US (7) | US8293737B2 (da) |
EP (2) | EP2540722B1 (da) |
JP (4) | JP5373613B2 (da) |
AU (1) | AU2007312936B2 (da) |
CA (2) | CA2666219C (da) |
DK (1) | DK2074123T3 (da) |
ES (1) | ES2399071T3 (da) |
HK (1) | HK1132268A1 (da) |
NZ (1) | NZ576036A (da) |
PL (1) | PL2074123T3 (da) |
PT (1) | PT2074123E (da) |
SI (1) | SI2074123T1 (da) |
WO (1) | WO2008046135A1 (da) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK2074123T3 (da) * | 2006-10-16 | 2013-01-14 | Bionomics Ltd | Nye anxiolytiske forbindelser |
US10954231B2 (en) | 2006-10-16 | 2021-03-23 | Bionomics Limited | Anxiolytic compounds |
WO2011031745A1 (en) | 2009-09-09 | 2011-03-17 | Achaogen, Inc. | Antibacterial fluoroquinolone analogs |
US9023848B2 (en) | 2011-03-02 | 2015-05-05 | Bionomics Limited | Small-molecules as therapeutics |
US20140051701A1 (en) * | 2011-03-02 | 2014-02-20 | Bionomics Limited | Methods of treating a disease or condition of the central nervous system |
NZ615466A (en) * | 2011-05-12 | 2016-02-26 | Bionomics Ltd | Methods for preparing naphthyridines |
WO2014036595A1 (en) * | 2012-09-04 | 2014-03-13 | Bionomics Limited | Compounds and methods for treating diseases or conditions associated with the central nervous system and/or neurite outgrowth |
WO2014138812A1 (en) * | 2013-03-15 | 2014-09-18 | Bionomics Limited | Salts, co-crystals, and polymorphs of an anxiolytic compound |
AU2013204159B2 (en) * | 2013-03-15 | 2015-05-07 | Bionomics Limited | A Crystalline Form of an Anxiolytic Compound |
WO2019109150A1 (en) * | 2017-12-07 | 2019-06-13 | Bionomics Limited | Methods of treating agitation |
AU2019361539A1 (en) * | 2018-10-18 | 2021-04-29 | Bionomics Limited | Cyclic compounds as receptor modulating therapeutics and methods and uses thereof |
EP4034113A4 (en) | 2019-09-23 | 2023-08-23 | Bionomics Limited | THERAPEUTIC FORMULATIONS AND THEIR USES |
Family Cites Families (79)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1022214A (en) * | 1963-01-31 | 1966-03-09 | Sterling Drug Inc | Novel 1,3-disubstituted-1,4-dihydro-4-oxo-1,7-naphthyridines and their preparation |
US3506668A (en) * | 1965-01-26 | 1970-04-14 | Sterling Drug Inc | Method of preparing 8-hydroxy-quinolines |
US3429887A (en) * | 1965-01-26 | 1969-02-25 | Sterling Drug Inc | 1,7-naphthyridine-3-carboxylic acid derivatives and their preparation |
JPS5023036B1 (da) | 1970-12-29 | 1975-08-05 | ||
JPS5023037B1 (da) | 1970-12-29 | 1975-08-05 | ||
JPS5023037A (da) | 1973-07-03 | 1975-03-12 | ||
JPS5023036A (da) | 1973-07-06 | 1975-03-12 | ||
JPS5132594A (en) * | 1974-09-11 | 1976-03-19 | Kanebo Ltd | 1 88 nafuchirijinjudotai no seiho |
JPS5331690A (en) * | 1976-09-01 | 1978-03-25 | Shionogi & Co Ltd | Oxadithiacephalosporins |
JPS54163596A (en) * | 1978-06-09 | 1979-12-26 | Daiichi Seiyaku Co | Flonaphlizine derivative |
JPS55111486A (en) | 1979-02-19 | 1980-08-28 | Dai Ichi Seiyaku Co Ltd | Preparation of pro 3,2,-b -1,8-naphthyridine derivative |
JPS55151584A (en) * | 1979-05-11 | 1980-11-26 | Dai Ichi Seiyaku Co Ltd | Preparation of 1,8-naphthyridine derivative |
JPS56115787A (en) * | 1980-02-19 | 1981-09-11 | Dai Ichi Seiyaku Co Ltd | Preparation of furo (3,2-b)(1,8)naphthyridine derivative |
JPS56118083A (en) * | 1980-02-22 | 1981-09-16 | Dai Ichi Seiyaku Co Ltd | Furo(3,2-b)(1,8)naphthyridine derivative |
JPS56118081A (en) * | 1980-02-22 | 1981-09-16 | Dai Ichi Seiyaku Co Ltd | Preparation of 6-methoxy-1,8-naphthyridine |
JPS5726688A (en) | 1980-07-24 | 1982-02-12 | Dai Ichi Seiyaku Co Ltd | Furo 3,2-b 1,8-naphthyridine-7-carboxylic acid derivative |
JPS57109790A (en) * | 1980-12-26 | 1982-07-08 | Dai Ichi Seiyaku Co Ltd | Furo(3,2-b)1,8-naphthyridine-7-carboxylic acid derivative |
US4404201A (en) | 1981-11-13 | 1983-09-13 | Warner-Lambert Company | Cephalosporins |
JPS5993080A (ja) * | 1982-11-18 | 1984-05-29 | Sumitomo Chem Co Ltd | 1,5−ナフチリジンカルボン酸誘導体 |
ATE113953T1 (de) | 1988-05-10 | 1994-11-15 | Ici Plc | Cephalosporine, verfahren zu ihrer herstellung und pharmazeutische präparate. |
US5095015A (en) * | 1990-07-24 | 1992-03-10 | Neurogen Corporation | Certain azacycloalkyl imidazopyrimidines; a new class of gaba brain receptor ligands |
US5182386A (en) * | 1991-08-27 | 1993-01-26 | Neurogen Corporation | Certain imidazoquinoxalinones; a new class of gaba brain receptor ligands |
US5182290A (en) * | 1991-08-27 | 1993-01-26 | Neurogen Corporation | Certain oxazoloquinolinones; a new class of GABA brain receptor ligands |
IT1251202B (it) * | 1991-09-13 | 1995-05-04 | Mediolanum Farmaceutici Spa | 6-amminochinoloni, sintesi ed impiego come antibatterici |
US5212310A (en) * | 1991-12-19 | 1993-05-18 | Neurogen Corporation | Certain aryl fused imidazopyrimidines; a new class of GABA brain receptor ligands |
US5306819A (en) * | 1992-08-27 | 1994-04-26 | Neurogen Corporation | Certain aryl a cycloalkyl fused imidazopyrazinols; and new class of GABA brain receptor ligands |
US5750702A (en) * | 1993-10-27 | 1998-05-12 | Neurogen Corporation | Certain pyrrolo pyridine-3-carboxamides; a new class of GABA brain receptor ligands |
US5484944A (en) * | 1993-10-27 | 1996-01-16 | Neurogen Corporation | Certain fused pyrrolecarboxanilides and their use as GABA brain receptor ligands |
US5804686A (en) * | 1996-01-19 | 1998-09-08 | Neurogen Corporation | fused pyrrolecarboxamides; a new class of GABA brain receptor ligands |
US6211365B1 (en) * | 1996-01-19 | 2001-04-03 | Neurogen Corporation | Fused pyrrolecarboxamides; a new class of GABA brain receptor ligands |
US6013650A (en) * | 1996-03-14 | 2000-01-11 | Neurogen Corporation | Certain aryl fused imidazopyrimidines; a new class of GABA brain receptor ligands |
WO1997034870A1 (en) * | 1996-03-22 | 1997-09-25 | Neurogen Corporation | Certain fused pyrrolecarboxamides as gaba brain receptor ligands |
US5723462A (en) * | 1996-04-26 | 1998-03-03 | Neurogen Corporation | Certain fused pyrrolecarboxamides a new class of GABA brain receptor ligands |
JP2001514181A (ja) * | 1997-08-25 | 2001-09-11 | ニューロゲン コーポレイション | Gaba脳レセプタリガンドとしての置換4−オキソ−ナフチリジン−3−カルボキサミド |
US6143760A (en) * | 1997-08-25 | 2000-11-07 | Neurogen Corporation | Substituted 4-oxo-napthyridine-3-carboxamides: GABA brain receptor ligands |
WO1999043682A1 (en) * | 1998-02-26 | 1999-09-02 | Neurogen Corporation | 2-(het-)aryl-4-(cyclic amino substituted) heteroaryl fused pyridine derivatives, their preparation and their use as (ant-)agonists for gaba (a) brain receptors |
DE19826050A1 (de) | 1998-06-12 | 1999-12-16 | Bayer Ag | Verfahren zur Herstellung von Chinolon- und Naphthyridoncarbonsäuren und deren Ester |
US6177569B1 (en) * | 1998-08-25 | 2001-01-23 | Neurogen Corporation | Oxo-pyridoimidazole-carboxamides: GABA brain receptor ligands |
US6414147B1 (en) * | 1998-12-23 | 2002-07-02 | Neurogen Corporation | 2-amino-9-alkylpurines: GABA brain receptor ligands |
ATE289593T1 (de) | 1999-05-06 | 2005-03-15 | Neurogen Corp | Substituierte 4-oxo-chinolin-3-carboxamide als gaba gehirnrezeptorliganden |
US6297256B1 (en) * | 1999-06-15 | 2001-10-02 | Neurogen Corporation | Aryl and heteroaryl substituted pyridino derivatives GABA brain receptor ligands |
EP1228069B1 (en) * | 1999-11-12 | 2003-04-02 | Neurogen Corporation | Bicyclic and tricyclic heteroaromatic compounds |
US6723332B2 (en) * | 2000-05-26 | 2004-04-20 | Neurogen Corporation | Oxomidazopyridine-carboxamides |
US6828329B2 (en) * | 2000-06-26 | 2004-12-07 | Neurogen Corporation | Aryl fused substituted 4-oxy-pyridines |
US6423956B1 (en) * | 2000-07-28 | 2002-07-23 | Optical Biopsy Technologies | Fiber-coupled, high-speed, integrated, angled-dual-axis confocal scanning microscopes employing vertical cross-section scanning |
JP2004506038A (ja) * | 2000-08-16 | 2004-02-26 | ニューロゲン コーポレイション | 2,4−置換ピリジン誘導体 |
WO2002020492A1 (en) * | 2000-09-06 | 2002-03-14 | Neurogen Corporation | Aryl substituted tetrahydroindazoles and their use as ligands for the gaba-a receptor |
US20020151591A1 (en) * | 2000-10-17 | 2002-10-17 | Anabella Villalobos | Combination use of acetylcholinesterase inhibitors and GABAa inverse agonists for the treatment of cognitive disorders |
AUPR283801A0 (en) | 2001-02-01 | 2001-03-01 | Australian National University, The | Chemical compounds and methods |
CN1494422A (zh) * | 2001-03-01 | 2004-05-05 | �Ʒ� | Gabaa反相激动剂与烟碱受体不完全激动剂、雌激素、选择性雌激素调节剂、或维生素e联合用于认知障碍的用途 |
MXPA03008681A (es) * | 2001-03-27 | 2004-04-02 | Neurogen Corp | (oxo-pirazol[1,5]pirimidin-2-il)alquil-carboxamidas. |
WO2003045920A1 (en) | 2001-11-27 | 2003-06-05 | Merck & Co., Inc. | 4-aminoquinoline compounds |
JP2005519876A (ja) | 2001-11-27 | 2005-07-07 | メルク エンド カムパニー インコーポレーテッド | 2−アミノキノリン化合物 |
CN1652784A (zh) | 2002-05-14 | 2005-08-10 | 加利福尼亚大学董事会 | 取代的喹诺酮羧酸、它们的衍生物、作用部位、以及其用途 |
IS7839A (is) * | 2002-11-22 | 2004-05-23 | Merck Frosst Canada Ltd. | 4-oxó-1-(3-setið fenýl-1,4-díhýdró-1,8-naftýridín-3-karboxamíð fosfódíesterasa-4 hindrar |
US7829694B2 (en) | 2002-11-26 | 2010-11-09 | Medtronic, Inc. | Treatment of neurodegenerative disease through intracranial delivery of siRNA |
TW200427688A (en) * | 2002-12-18 | 2004-12-16 | Glaxo Group Ltd | Antibacterial agents |
TW200418835A (en) | 2003-01-24 | 2004-10-01 | Tanabe Seiyaku Co | A pyrazolopyrimidine compound and a process for preparing the same |
JP2005162726A (ja) * | 2003-01-24 | 2005-06-23 | Tanabe Seiyaku Co Ltd | ピラゾロピリミジン化合物およびその製法 |
US20050031652A1 (en) | 2003-02-25 | 2005-02-10 | Allergan, Inc. | Compositions and methods comprising memantine and polyanionic polymers |
JP2006514964A (ja) * | 2003-03-12 | 2006-05-18 | アボット・ラボラトリーズ | 抗菌剤としてのナフチリジン誘導体 |
DE102004004971B3 (de) | 2004-01-31 | 2005-09-15 | Aventis Pharma Deutschland Gmbh | Cycloalkyl substituierte 7-Amino-4-chinolon-3-carbonsäure-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arnzeimittel |
DE102004004972B3 (de) * | 2004-01-31 | 2005-09-15 | Aventis Pharma Deutschland Gmbh | Heterocyclisch substituierte 7-Amino-4-chinolon-3-carbonsäure-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
US7402674B2 (en) * | 2004-01-31 | 2008-07-22 | Sanofi-Aventis Deutschland Gmbh, | 7-Phenylamino-4-quinolone-3-carboxylic acid derivatives, process for their preparation and their use as medicaments |
OA13364A (en) | 2004-01-31 | 2007-04-13 | Sanofi Aventis Deutschland | 7-phenylamino-4-quinolone-3-carboxylic acid derivatives, methods for production and use thereof as medicaments. |
US7470706B2 (en) * | 2004-01-31 | 2008-12-30 | Sanofi-Aventis Deutschland Gmbh | Cycloalkyl-substituted 7-amino-4-quinolone-3-carboxylic acid derivatives, process for their preparation and their use as medicaments |
US7498341B2 (en) * | 2004-01-31 | 2009-03-03 | Sanofi Aventis Deutschland Gmbh | Heterocyclically substituted 7-amino-4-quinolone-3-carboxylic acid derivatives, process for their preparation and their use as medicaments |
PE20060285A1 (es) | 2004-03-30 | 2006-05-08 | Aventis Pharma Inc | Piridonas sustituidas como inhibidores de pol(adp-ribosa)-polimerasa (parp) |
ES2348246T3 (es) | 2004-11-01 | 2010-12-01 | F. Hoffmann-La Roche Ag | Quinolinas como activadores alostéricos de receptores gaba-b. |
JP2008521905A (ja) | 2004-12-03 | 2008-06-26 | メルク エンド カムパニー インコーポレーテッド | キノリンタキキニン受容体拮抗薬 |
AU2006254255A1 (en) | 2005-06-02 | 2006-12-07 | F. Hoffmann-La Roche Ag | 3-methanesulfonylquinolines as GABA-B enhancers |
CA2624105C (en) | 2005-09-29 | 2014-02-18 | Sanofi-Aventis | Phenyl-[1,2,4]-oxadiazol-5-one derivatives with phenyl group, processes for their preparation and their use as pharmaceuticals |
TW200824678A (en) | 2006-08-11 | 2008-06-16 | Combinatorx Inc | Methods and compositions for the treatment of neurodegenerative disorders |
DK2074123T3 (da) | 2006-10-16 | 2013-01-14 | Bionomics Ltd | Nye anxiolytiske forbindelser |
AR076687A1 (es) | 2009-05-18 | 2011-06-29 | Infinity Pharmaceuticals Inc | Isoxazolinas como inhibidores de la amidahidrolasa de acidos grasos y com-posiciones farmaceuticas que los contienen |
DK2672823T3 (da) | 2011-02-07 | 2016-11-28 | Biogen Ma Inc | S1p-modulerende midler |
US9023848B2 (en) | 2011-03-02 | 2015-05-05 | Bionomics Limited | Small-molecules as therapeutics |
US20140051701A1 (en) | 2011-03-02 | 2014-02-20 | Bionomics Limited | Methods of treating a disease or condition of the central nervous system |
NZ615466A (en) | 2011-05-12 | 2016-02-26 | Bionomics Ltd | Methods for preparing naphthyridines |
-
2007
- 2007-10-16 DK DK07815371.5T patent/DK2074123T3/da active
- 2007-10-16 JP JP2009531697A patent/JP5373613B2/ja active Active
- 2007-10-16 AU AU2007312936A patent/AU2007312936B2/en active Active
- 2007-10-16 EP EP12186384.9A patent/EP2540722B1/en active Active
- 2007-10-16 NZ NZ576036A patent/NZ576036A/en not_active IP Right Cessation
- 2007-10-16 EP EP07815371A patent/EP2074123B1/en active Active
- 2007-10-16 CA CA2666219A patent/CA2666219C/en active Active
- 2007-10-16 ES ES07815371T patent/ES2399071T3/es active Active
- 2007-10-16 PT PT78153715T patent/PT2074123E/pt unknown
- 2007-10-16 WO PCT/AU2007/001566 patent/WO2008046135A1/en active Application Filing
- 2007-10-16 PL PL07815371T patent/PL2074123T3/pl unknown
- 2007-10-16 US US12/311,872 patent/US8293737B2/en active Active
- 2007-10-16 SI SI200731109T patent/SI2074123T1/sl unknown
- 2007-10-16 CA CA2954376A patent/CA2954376C/en active Active
-
2009
- 2009-12-15 HK HK09111778.6A patent/HK1132268A1/xx unknown
-
2012
- 2012-09-14 US US13/617,317 patent/US8614212B2/en active Active
- 2012-09-14 US US13/617,153 patent/US8551990B2/en active Active
-
2013
- 2013-05-20 JP JP2013106650A patent/JP5739476B2/ja active Active
- 2013-09-18 US US14/030,808 patent/US8906912B2/en active Active
-
2014
- 2014-11-05 US US14/533,808 patent/US9573945B2/en active Active
-
2015
- 2015-04-23 JP JP2015088672A patent/JP6138191B2/ja active Active
-
2017
- 2017-01-04 US US15/398,472 patent/US9975892B2/en active Active
- 2017-02-08 JP JP2017021529A patent/JP6506322B2/ja active Active
- 2017-12-15 US US15/844,295 patent/US10233181B2/en active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
LTC2004635I2 (lt) | Pakeistieji enaminokarbonilo junginiai | |
CY2017016I1 (el) | Αναστολεις πρωτεασωματος | |
DK2074123T3 (da) | Nye anxiolytiske forbindelser | |
ATE502948T1 (de) | Substituierte bicyclolactamverbindungen | |
DK2061766T3 (da) | Nye forbindelser | |
BRPI0813500A2 (pt) | Compostos antivirais | |
BRPI0821086A2 (pt) | Compostos inseticidas | |
ATE510825T1 (de) | Acylaminopyrazole als fgfr-inhibitoren | |
ATE542825T1 (de) | Substituierte piperidino-dihydrothienopyrimidine | |
ATE524477T1 (de) | Aziridinylepothilonverbindungen | |
SMT201600045B (it) | Composti tetraciclinici c7-fluoro sostituiti | |
DK2086960T3 (da) | Nye inhibitorer af glutaminylcyclase. | |
BRPI0815042A2 (pt) | Compostos de pirazol | |
DE602008003015D1 (de) | Heterocyclische spiroverbindungen | |
ATE463498T1 (de) | Imidazo-verbindungen | |
BRPI0811264A2 (pt) | Compostos | |
ATE506358T1 (de) | 2-benzylpyridazinonderivate als met-kinasehemmer | |
DK2120936T3 (da) | Nye fremgangsmåder | |
DK2234976T3 (da) | Nye pyrazol-substituerede arylamider | |
BRPI0814424A2 (pt) | Compostos heterociclila | |
BRPI0720224A2 (pt) | Arilpirazóis substituídos | |
ITMI20060943A1 (it) | Nessuno | |
BRPI0809996A2 (pt) | Compostos | |
DE502006004094D1 (de) | Bohrfutter | |
BRPI0815181A2 (pt) | Compostos |